Amneal Begins Supplying Over-the-Counter Naloxone Hydrochloride Nasal Spray to U.S. Retail Pharmacies and the State of California
BRIDGEWATER, N.J.--(BUSINESS WIRE)--May 22, 2024--
Source: eagletribune.com
📰 Anthony Dimeo News
Anthony Dimeo News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Anthony Dimeo. Real-time updates on events, politics, business and more.
California cuts cost of overdose-reversal drug by 40% in generic deal
Under the deal with Amneal Pharmaceuticals, the state will buy twin packs of naloxone nose spray for $24, or about 40 percent less than what it currently pays for a similar product, Governor Gavin Newsom said in a statement Monday.
Source: bostonglobe.com
Amneal and BIAL Announce U.S. Licensing Agreement for ONGENTYS® (opicapone)
ONGENTYS® (opicapone) is a leading adjunctive therapy for the treatment of Parkinson’s DiseaseComplements Amneal’s existing Parkinson’s franchise and further expands specialty portfolioBRIDGEWATER, N.J. & PORTO, Portugal--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal”) and BIAL - Portela &...
Source: pharmiweb.com
Amneal Expands Portfolio with Addition of Icosapent Ethyl Acid Soft Gel Capsules
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Dec 1, 2023--
Source: eagletribune.com
Amneal Pharmaceuticals, Inc. (NYSE:AMRX) Q3 2023 Earnings Call Transcript
Anthony DiMeo: Good morning, and thank you for joining Amneal Pharmaceuticals Third Quarter 2023 Earnings Call. Today, we issued a press release reporting our Q3 results.
Source: insidermonkey.com
Amneal to Report Third Quarter 2023 Results on November 7, 2023
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Oct 5, 2023--
United States Anthony Dimeo Amneal Pharmaceuticals Inc Investor Relations Amneal Pharmaceuticals Business Wire
Source: eagletribune.com
Amneal Receives U.S. FDA Approval for Lisdexamfetamine Dimesylate
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Sep 6, 2023--
United States Anthony Dimeo Andrew Boyer Amneal Pharmaceuticals Inc Drug Administration Exchange Commission
Source: eagletribune.com
Amneal Pharmaceuticals, Inc. (NYSE:AMRX) Q2 2023 Earnings Call Transcript
Operator: Hello, everyone and welcome to the Amneal Pharmaceuticals Second Quarter 2023 Earnings Conference Call. My name is Bruno, and I’ll be operating your call today.
Source: insidermonkey.com
New Jersey Blueberry season aproaching
In this installment of the ‘Agronometrics In Charts’ series, Sarah Ilyas studies the state of the New Jersey Blueberry season.
Source: freshfruitportal.com
Amneal Receives U.S. FDA Complete Response Letter for IPX203
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Jul 3, 2023--
United States Anthony Dimeo Chintu Patel Exchange Commission Amneal Pharmaceuticals Inc Company New Drug Application
Source: galvnews.com